BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/16/2023 9:24:22 AM | Browse: 105 | Download: 187
 |
Received |
|
2023-02-19 10:19 |
|
Peer-Review Started |
|
2023-02-19 10:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-02-28 08:03 |
|
Revised |
|
2023-03-17 11:06 |
|
Second Decision |
|
2023-04-06 03:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2023-04-06 07:52 |
|
Articles in Press |
|
2023-04-06 07:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-05-04 06:12 |
|
Publish the Manuscript Online |
|
2023-05-16 09:24 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Control Study |
| Article Title |
Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qing-Hua Zhu, Jing-Kun Wu and Gao-Lei Hou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hebei Medical Science Research Project |
20220648 |
|
| Corresponding Author |
Jing-Kun Wu, MM, Associate Chief Physician, Department of Neurosurgery, Affiliated Hospital of Hebei Engineering University, No. 81 Congtai Street,Congtai District, Handan 056002, Hebei Province, China. wujingkunwjk@163.com |
| Key Words |
Glioma; Ubiquitin carboxy-terminal hydrolase L1; Glial fibrillary acidic protein; Surgery; Prognosis; Clinical significance |
| Core Tip |
Since the recurrence rate of glioma is high, it is important to early predict its prognosis. Ubiquitin carboxy-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) are important markers for nervous system damages and lesions. Therefore, we evaluated the changes in UCH-L1 and GFAP levels in patients with glioma during the perioperative period and compared them with those in healthy volunteers to analyze their relationship with clinicopathological and postoperative recurrence. These results revealed that UCH-L1 and GFAP might reflect the development and recurrence of glioma and could be used as potential indicators to estimate prognosis of glioma. |
| Publish Date |
2023-05-16 09:24 |
| Citation |
Zhu QH, Wu JK, Hou GL. Changes and significance of serum ubiquitin carboxyl-terminal hydrolase L1 and glial fibrillary acidic protein in patients with glioma. World J Clin Cases 2023; 11(14): 3158-3166 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i14/3158.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i14.3158 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
